SELLAS Life Sciences Group, Inc.
15 West 38th St., 10th Floor
New York, New York 10018
June 9, 2020
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||SELLAS Life Sciences Group, Inc.|
|Registration Statement on Form S-1|
|File No. 333-238799|
Dear Ms. Bednarowski,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-238799), so that it may become effective at 4:00 p.m. (Washington, D.C. time) on Thursday, June 11, 2020, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
|Very truly yours,|
|SELLAS Life Sciences Group, Inc.|
|/s/ Angelos M. Stergiou|
|By: Angelos M. Stergiou, M.D., Sc.D., h.c.|
|Its: President and Chief Executive Officer|
|cc:||Barbara A. Wood, SELLAS Life Sciences Group, Inc.|
|Daniel A. Bagliebter, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.|